Literature DB >> 8871586

Exercise fuel mobilization in mitochondrial myopathy: a metabolic dilemma.

J Vissing1, H Galbo, R G Haller.   

Abstract

In mitochondrial myopathy, severely impaired muscle oxidative capacity poses a dilemma for metabolic regulation in exercise. We inquired whether fuel mobilization during exercise in mitochondrial myopathy is adjusted to the reduced capacity to oxidize substrate, or if fuel is mobilized in excess of oxidative capacity. Hormonal and metabolic responses to 20 minutes of cycle exercise were studied in 4 patients with mitochondrial myopathy working at near maximal effort and in 4 healthy matched controls. On 2 separate days, controls were studied at the same absolute (A) workload (9 +/- 3 W) and the same relative (R) workload (77 +/- 9 W) as performed by the patients. During exercise, average glucose production was higher in patients (28 +/- 5 micromol min(-1) kg(-1)) than in controls at both workloads (A, 12 +/- 1; R, 18 +/- 2 micromol min(-1) kg(-1)). Exercise-induced increases in plasma glucose, growth hormone, epinephrine, norepinephrine, corticotropin, and lactate, and decreases in plasma insulin and pH were also larger in patients compared with findings in controls at both workloads. In conclusion, mitochondrial myopathies are associated with excessive neuroendocrine responses and mobilization of glucose during exercise. These responses augment ATP synthesis but result in progressive accumulation of nonoxidized substrates. Apparently, substrate mobilization and neuroendocrine responses in exercise are linked to oxidative demand rather than to oxidative capacity in working muscle.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1996        PMID: 8871586     DOI: 10.1002/ana.410400416

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

Review 1.  Glucoregulation during exercise : the role of the neuroendocrine system.

Authors:  Robert H Coker; Michael Kjaer
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

2.  Exertional dyspnea in mitochondrial myopathy: clinical features and physiological mechanisms.

Authors:  Katja Heinicke; Tanja Taivassalo; Phil Wyrick; Helen Wood; Tony G Babb; Ronald G Haller
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-03       Impact factor: 3.619

3.  Blunted fat oxidation upon submaximal exercise is partially compensated by enhanced glucose metabolism in children, adolescents, and young adults with Barth syndrome.

Authors:  William Todd Cade; Kathryn L Bohnert; Linda R Peterson; Bruce W Patterson; Adam J Bittel; Adewole L Okunade; Lisa de Las Fuentes; Karen Steger-May; Adil Bashir; George G Schweitzer; Shaji K Chacko; Ronald J Wanders; Christina A Pacak; Barry J Byrne; Dominic N Reeds
Journal:  J Inherit Metab Dis       Date:  2019-04-11       Impact factor: 4.982

Review 4.  Metabolic myopathies: functional evaluation by different exercise testing approaches.

Authors:  L Volpi; G Ricci; D Orsucci; R Alessi; F Bertolucci; S Piazza; C Simoncini; M Mancuso; G Siciliano
Journal:  Musculoskelet Surg       Date:  2011-03-04

5.  Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies.

Authors:  J Vissing; S F Vissing; D A MacLean; B Saltin; B Quistorff; R G Haller
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

6.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

7.  Lactate stress testing by bedside lactate determination.

Authors:  Josef Finsterer
Journal:  Metab Brain Dis       Date:  2003-12       Impact factor: 3.584

8.  Defining cardiac adaptations and safety of endurance training in patients with m.3243A>G-related mitochondrial disease.

Authors:  Matthew G D Bates; Jane H Newman; Djordje G Jakovljevic; Kieren G Hollingsworth; Charlotte L Alston; Pawel Zalewski; Jacek J Klawe; Andrew M Blamire; Guy A MacGowan; Bernard D Keavney; John P Bourke; Andrew Schaefer; Robert McFarland; Julia L Newton; Douglass M Turnbull; Robert W Taylor; Michael I Trenell; Gráinne S Gorman
Journal:  Int J Cardiol       Date:  2013-06-03       Impact factor: 4.164

9.  Altered skeletal muscle (mitochondrial) properties in patients with mitochondrial DNA single deletion myopathy.

Authors:  Saskia Maria Gehrig; Violeta Mihaylova; Sebastian Frese; Sandro Manuel Mueller; Maria Ligon-Auer; Christina M Spengler; Jens A Petersen; Carsten Lundby; Hans H Jung
Journal:  Orphanet J Rare Dis       Date:  2016-07-29       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.